Global Braze Alloys Market: Snapshot

Globally, the number of people affected by high blood pressure and large number of people are having valvular heart disease caused by rheumatic fever has resulted in atrial fibrillation. Growing incidence of obesity, hypertension, and diabetes has also resulted in different heart diseases leading the growth in the global atrial fibrillation. Moreover, increasing medical research and development activities and advancement seen in treatment and diagnoses of atrial fibrillation are also expected to expand the global atrial fibrillation market in the forthcoming years.

As per the data released in 2017 by the Centers for Disease Control and Prevention, 2.7–6.1 million individuals suffer from atrial fibrillation in the U.S. Increasing geriatric population is expected to add in the number in the coming years. Nearly 2% of the population under 65 years of age suffers from atrial fibrillation. Depending on these figures, there are high chances of growth in the global atrial filtration market.

Large number of geriatric population is a crucial factor that has surged growth in this market. Pertaining to these factors, the global atrial fibrillation market is likely to progress at 11.0% CAGR between 2017 and 2026. Rising at this rate, the market is expected to reach US$10.92 bn by the end of 2026.

Global Atrial Fibrillation Market

EP Ablation Catheters to Hold Dominant Share in Atrial Fibrillation Market

The global atrial fibrillation market is categorized on the basis of product type, end user, and application. Based on product type the market is divided into EP diagnostic catheters, cardiac monitors, EP mapping and recording systems, EP ablation catheters, LAA closure, access devices, and others. Out of these, the demand for EP ablation catheters is competitively high than other products. Over the forecast tenure, this segment is expected to attain a valuation of US$2.7 bn by the end of 2026. In the meantime, EP mapping and recording systems are also expected to witness high growth over this period.

The application of atrial fibrillation is seen in surgical, EP ablation, and diagnostics. Of these, the EP ablation segment is expected to hold larger share in the global atrial fibrillation market. In terms of end user, the market is segmented into hospitals, electrophysiology labs, and ambulatory surgical center. Among these end users, hospitals are projected to witness high demand over the projected tenure.

Europe Dominating Atrial Fibrillation Market Due to Advanced Healthcare Infrastructure

On the regional front, the global atrial fibrillation market covers North America, Europe, Latin America, the Middle East and Africa, and Asia Pacific. Among these, Europe is projected to lead the global atrial fibrillation market over the forecast period. Significant rise in adoption of advanced technologies and development of advanced healthcare infrastructure and facilities are the key factors fueling growth in the Europe atrial fibrillation market. Germany has a higher role in this market, as various catheter ablation procedures are performed in this region. This factor has further strengthen position of Europe in the global atrial fibrillation market.

In the competitive landscape section, the global atrial fabrillation market is likely to witness higher degree of competition due to the presence of large number of players operating in this market. In this report, researchers have analyzed few leading players including Biosense Webster, Inc., Medtronic Plc, Abbott Laboratories, Osypka AG, Biotronik SE & Co. KG, Boston Scientific Corporation, AtriCure Inc., MicroPort Scientific Corporation, CardioFocus, Inc., and Koninklijke Philips N.V. 

Global Atrial Fibrillation Market: Overview

Atrial fibrillation is an irregular heartbeat identified by the rapid and abnormal beating of the heart. The global market for atrial fibrillation is majorly driven by the rise in high blood pressure and valvular heart disease. Meanwhile, increasing prevalence of atrial fibrillation among the geriatric population is also fueling the growth of the market. Significant technological advancement is leading to the development of new monitoring technologies that can help patients as well as clinicians to keep a close watch and treat it on time. Smart, wireless, easy-to-use, cost-effective, and efficient monitoring systems are also being focused on to monitor the heartbeat. These developments present a major opportunity for key players operating in atrial fibrillation space.

Innovative technologies with the ability to target the causes of atrial fibrillation have led to the maximum success rate of treating the condition. The key market players are also entering into a partnership with research institutes and other companies to develop an efficient system to detect and treat atrial fibrillation.

Global Atrial Fibrillation Market: Research Methodology

The research is based on primary and secondary research, done for understanding the trends, drivers, opportunity, restraints, etc. The research is done to forecast the expected revenue of the global atrial fibrillation market. Primary research is based on the information collected from interviews and discussions with a number of industry experts and opinion leaders.

Secondary research includes the study of company websites, press releases, annual reports, investor and analyst presentation, and various other factors. The report also offers an estimated market size in terms of US$ Mn for product type, end-user, and application for the forecast period of 2017 to 2026. The report also takes into account the macro and micro factors that are affecting the market. The report also offers Porter’s five force analysis and SWOT analysis. An in-depth analysis of factors resulting in driving and restraining growth of the market and future opportunities has been provided in the report. The report also offers market attractiveness analysis that provides an analysis of the competitive scenario in the global atrial fibrillation market.

Global Atrial Fibrillation Market: Segmentation

The global atrial fibrillation market is segmented on the basis of product type, end user, and application. Based on the product type, the market is segmented into EP diagnostic catheters, EP ablation catheters, cardiac monitors, EP mapping & recording systems, LAA closure, access devices, and other products. On the basis of end user, the market is segmented on the basis of hospitals, ambulatory surgical center, and electrophysiology labs. By application type, the market includes EP ablation, diagnostic, and surgical. The market growth rate for each segment within the global atrial fibrillation market has been provided after an in-depth research on past trends, future trends demographics, various regulatory requirements, and technological developments.

On the basis of region, the market is segmented on the basis of North America, Europe, Latin America, Asia Pacific Excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). The forecast for each region has been provided for the year 2017-2026, on the basis of product type, end user, and application. The report also provides revenue share and CAGR in form of percentage for each segment.

Global Atrial Fibrillation Market: Competition Landscape

The report provides market share analysis of the key players in the global atrial fibrillation market. The report also offers in-depth information for new entrants and established players to expand geographically and also increase their revenue share. Some of the key players in the report include Biosense Webster, Inc., Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG, Koninklijke Philips N.V., AtriCure Inc., CardioFocus, Inc., and Osypka AG. 

.